黑料网

Journal of Biochemical and Microbial Toxicology
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Awards & Nominations
Publication Policies and Ethics
Useful Links
Share This Page

Anthrax toxin

Anthrax toxin is a three-protein exotoxin secreted by virulent strains of the bacterium, bacillus anthracis-the causative agent of anthrax. The toxin was first discovered by Harry Smith in 1954. Anthrax toxin is composed of a cell-binding protein, known as protective antigen (PA), and two enzyme components, called Edema factor (EF) and Lethal factor (LF). These three protein components act together to impart their physiological effects. Anthrax is a disease caused by bacillus anthracis, a spore-forming, gram positive, rod-shaped bacterium. The lethality of the disease is caused by the bacterium's two principal virulence factors: (i) the polyglutamic acid capsule, which is anti-phagocytic, and (ii) the tripartite protein toxin, called anthrax toxin. Anthrax toxin is a mixture of three protein components: (i) protective antigen (PA), (ii) edema factor (EF), and (iii) lethal factor (LF). Toxic symptoms are not observed when these proteins are injected individually into laboratory animals.

Related Journals: Journal of Critical reviews in Microbiology, Research Journal of  Toxins, International Journal of Current Toxins Research.

 

Anthrax toxin

Expert PPTs

Speaker PPTs

  • Jalil Mehrzd
    Bioluminescence-based detection of brain immune cells apoptosis and ATP depletion induced by aflatoxin B1
    | PDF Version
  • Ben Nelson
    Purity, endotoxin level, and trace metal comparison of different grades of trehalose
    | PDF Version
  • Ivan U. Kouzel
    Glycosphingolipid-mediated interaction of Shiga toxin with the human endothelium: status quo of receptor research
    | PDF Version
  • Xingmin Sun
    A chimeric protein (mTcd138) comprising the glucosyltransferase and domains of toxin B and the receptor binding domain of toxin A provides full protection against Clostridium difficile infection in mice
    | PDF Version
  • Ming-Hsien Wang
    Cytotoxic Necrotizing Factor-1 Toxin in Uropathogenic E. coli: Is There a Role for Virulence Factors in Urinary Tract Infection?
    | PDF Version
  • Dominique Batifol
    Intra-articular injection of Botulinum toxin analgesic effect
    | PDF Version
  • Carlos Corassin
    Efficiency of different sources of Saccharomyces cerevisiae for decontamination of aflatoxin B1 in phosphate buffer saline solution
    | PDF Version
  • Gaylen Uhlich
    Production and regulation of functional amyloid curli fimbriae by Shiga toxin-producing Escherichia coli.
    | PDF Version
Conference Proceedings